Protocol No.: CLFT218-2401

A Double-blind, Placebo-controlled, Randomized Withdrawal, Multicenter Study of the Efficacy and safety of FT218 in the Treatment of Idiopathic Hypersomnia (IH) with an Open-Label Safety Extension
Principal Investigator
Azzouz, Mouhannad
Phase
III
Age Group
Adult
Applicable Disease Site
Other
Participating Institutions
Health Sciences Center
West Virginia University
Contact
Lauren Chase, RN
Clinical Research Specialist
Phone: +1 304-598-4000

View on ClinicalTrials.gov